For comments, suggestions
Created with Raphaël 2.1.0 07.04.2017 Filing date 08.11.2018 Validation fee payment 31.03.2019 (A1) Patent application published 26.05.2022 AGEPI application filing date 30.09.2022 (T2) Translation of the validated European patent 18.06.2026 07.04.2027 Valid until 08.04.2028 Renewal fee to be paid until 07.04.2037 Patent will expire on

Patent in force


(210)Number of the EPO application17717845
(220)Filing date of the EPO application2017.04.07
(80)EPO patent specification publication (B)EPB nr. 17/2022, 2022.04.27
(110)EPO patent number3440105
(11)Number of the documentMD 3440105 T2
(21)Number of the applicatione 2019 0184
(71)Name(s) of applicant(s), code of the countryImmunocore Limited, GB;
(72)Name(s) of inventor(s), code of the countryHAYES Conor, GB;
HIBBERT Linda, GB;
LIDDY Nathaniel, GB;
MAHON Tara, GB;
RAMAN Marine, GB;
(73)Name(s) of owner(s), code of the countryImmunocore Limited, GB;
(54)Title of the inventionT cell receptors
(13)Kind-of-document code T2
(51)International Patent Classification C07K 14/725 (2006.01.01)
(19)CountryGB
(41)Date of publication of the application2019.03.31
(49)Date of publication of the translation of the validated European patent specification2022.09.30
(30)Priority201606009, 2016.04.08, GB
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/GB2017/050985, 2017.04.07
(87)International publicationWO 2017/175006, 2017.10.12
Up
/Inventions/details/3440105